Literature DB >> 24870944

Thermodynamic phase behavior of API/polymer solid dispersions.

Anke Prudic1, Yuanhui Ji, Gabriele Sadowski.   

Abstract

To improve the bioavailability of poorly soluble active pharmaceutical ingredients (APIs), these materials are often integrated into a polymer matrix that acts as a carrier. The resulting mixture is called a solid dispersion. In this work, the phase behaviors of solid dispersions were investigated as a function of the API as well as of the type and molecular weight of the carrier polymer. Specifically, the solubility of artemisinin and indomethacin was measured in different poly(ethylene glycol)s (PEG 400, PEG 6000, and PEG 35000). The measured solubility data and the solubility of sulfonamides in poly(vinylpyrrolidone) (PVP) K10 and PEG 35000 were modeled using the perturbed-chain statistical associating fluid theory (PC-SAFT). The results show that PC-SAFT predictions are in a good accordance with the experimental data, and PC-SAFT can be used to predict the whole phase diagram of an API/polymer solid dispersion as a function of the kind of API and polymer and of the polymer's molecular weight. This remarkably simplifies the screening process for suitable API/polymer combinations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24870944     DOI: 10.1021/mp400729x

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  16 in total

1.  Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.

Authors:  Kristin Lehmkemper; Samuel O Kyeremateng; Matthias Degenhardt; Gabriele Sadowski
Journal:  Pharm Res       Date:  2018-01-05       Impact factor: 4.200

2.  A Novel Approach for Analyzing the Dissolution Mechanism of Solid Dispersions.

Authors:  Yuanhui Ji; Raphael Paus; Anke Prudic; Christian Lübbert; Gabriele Sadowski
Journal:  Pharm Res       Date:  2015-02-27       Impact factor: 4.200

Review 3.  Physical Stability of Amorphous Solid Dispersions: a Physicochemical Perspective with Thermodynamic, Kinetic and Environmental Aspects.

Authors:  Xia Lin; Yang Hu; Lei Liu; Lili Su; Na Li; Jing Yu; Bo Tang; Ziyi Yang
Journal:  Pharm Res       Date:  2018-04-23       Impact factor: 4.200

Review 4.  Melt extrusion with poorly soluble drugs - An integrated review.

Authors:  Michael A Repka; Suresh Bandari; Venkata Raman Kallakunta; Anh Q Vo; Haley McFall; Manjeet B Pimparade; Ajinkya M Bhagurkar
Journal:  Int J Pharm       Date:  2017-11-02       Impact factor: 5.875

Review 5.  Quality-by-design in hot melt extrusion based amorphous solid dispersions: An industrial perspective on product development.

Authors:  Arun Butreddy; Suresh Bandari; Michael A Repka
Journal:  Eur J Pharm Sci       Date:  2020-11-28       Impact factor: 4.384

6.  Validation of Model-Based Melt Viscosity in Hot-Melt Extrusion Numerical Simulation.

Authors:  Esther S Bochmann; Andreas Gryczke; Karl G Wagner
Journal:  Pharmaceutics       Date:  2018-08-18       Impact factor: 6.321

Review 7.  Developing HME-Based Drug Products Using Emerging Science: a Fast-Track Roadmap from Concept to Clinical Batch.

Authors:  Josip Matić; Amrit Paudel; Hannes Bauer; Raymar Andreina Lara Garcia; Kinga Biedrzycka; Johannes G Khinast
Journal:  AAPS PharmSciTech       Date:  2020-06-22       Impact factor: 3.246

8.  Amorphous-Amorphous Phase Separation in API/Polymer Formulations.

Authors:  Christian Luebbert; Fabian Huxoll; Gabriele Sadowski
Journal:  Molecules       Date:  2017-02-15       Impact factor: 4.411

9.  A Novel Rheological Method to Assess Drug-Polymer Interactions Regarding Miscibility and Crystallization of Drug in Amorphous Solid Dispersions for Oral Drug Delivery.

Authors:  Georgia Tsakiridou; Christos Reppas; Martin Kuentz; Lida Kalantzi
Journal:  Pharmaceutics       Date:  2019-11-22       Impact factor: 6.321

10.  In-Silico Screening of Lipid-Based Drug Delivery Systems.

Authors:  Joscha Brinkmann; Lara Exner; Christian Luebbert; Gabriele Sadowski
Journal:  Pharm Res       Date:  2020-11-23       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.